Earnings call Ambu delivered Q2 organic revenue growth of 7.3% (Endoscopy Solutions +13.8%, Anesthesia & Patient Monitoring -2.5%), with EBIT margin at 10.8% ...

As lung cancer screening identifies an estimated 1.6 million suspicious lung nodules each year in the U.S. alone, physicians face a challenge. Most peripheral pulmonary lesions are benign, yet the ...

The MarketWatch News Department was not involved in the creation of this content. High-suction device is designed to maximize control, clarity, and confidence in critical settings. EL SEGUNDO, Calif.- ...

Good morning. I'm David Adlington. I head up the research team for medtech for JPMorgan in London. It's my pleasure to introduce Britt Meelby Jensen, CEO of Ambu, and there'll be Q&A afterwards this.

Hello, everyone, and welcome to this conference call presenting our Q4 and full year results from 2024, '25 for Ambu. My name is Britt Meelby Jensen. I'm the CEO of Ambu. And with me today, I have ...

When James Tamay went in last February, he didn’t know what he would learn when he woke up. At an ER visit a short time before, a test had found a spot on his lungs — and though that would generally ...

Earnings call Ambu delivered 13.1% organic revenue growth for FY 2024-25, with Endoscopy Solutions up 15.4% and EBIT margin at 13.0%, both in line with prior guidance despite FX and tariff headwinds.

Olympus has issued a voluntary correction for its bronchoscopes used with laser therapy, argon plasma coagulation or high-frequency cauterization equipment, following potential combustion risk. The ...

The update covers the use of Olympus bronchoscopes with laser therapy, argon plasma coagulation or high-frequency cauterization equipment in procedures targeting the branching tree of airways that get ...

Denmark’s Ambu will buy SkyGate’s Penang factory for about 61 million kr, with completion targeted by July 2026. Photo: Ritzau. SkyGate Solutions has agreed to sell a 1.8-acre leasehold factory in ...